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Introduction
 Children with Autism Spec-
trum Disorder (ASD) present a dis-
tinctive set of symptoms which affect 
areas of socialization, communica-
tion, and volition (American Psychi-
atric Association, 2013). Of these, 
Self-Injurious Behaviors (SIB) may 
be one of the most grave. Self-Injuri-
ous Behaviors are defined as, “a class 
of behaviors, often highly repetitive 
and rhythmic, that result in physical 
harm to the individual displaying 
the behavior” (Fee & Matson, 1992, 
4). These repetitive behaviors in-
clude pulling hair or skin, picking 
skin, biting self, inserting fingers 
or objects into bodily orifices, and 
other hand-to-head and hand-to-
body injuries (Lam & Aman, 2007). 
Researchers have concluded that 
of a variety of consequences from 
SIB, the most detrimental are tissue 
damage, disfigurement, health risks 
due to infection, and stigmatizing 
consequences (Humenik, Curran, 
Luiselli, & Child, 2008). There 
exists considerable debate on the 
prevalence of SIB in ASD. The 
research of Janicki and Jacobson 
(1983) posited that 20% of children 
diagnosed with autism display some 
form of SIB. In contrast, the more 
recent findings of Baghdadli, Pascal, 
Grisi, and Aussilloux (2003) indic-
ated that SIB is prevalent in 50% 
of children with ASD, with 14.6% 
demonstrating SIB at severe levels. 
 A number of hypotheses 
attempt to illustrate the etiology 
of SIB while little consensus ex-
ists within the clinical ranks on 
treatment. This is indicated by the 
controversy that surrounds the use of 
Electroconvulsive Therapy (ECT) in 
treating severe forms of this condi-
tion. A negative view of the therapy, 
reinforced by representations in 
popular culture, has been enshrined 
in the laws of states such as Cali-
fornia, Colorado, Tennessee, and 
Texas, to name a few (Consoli, et 
al., 2012). Meanwhile, some authors 
have augmented these concerns 
by stating their opposition to the 
practice for ethical reasons and the 
risk of various secondary cognitive 
side effects (Baker, 1995). Nonethe-
less, experts have concluded that 
alternative therapies, such as psycho-
tropic medication and behavioral 
therapy do not succeed in treating 
all patients (Food and Drugs Ad-
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ministration, 2014). The severity of 
SIB and its consequences heightens 
the need to determine the effective-
ness of ECT. The focus of this paper 
is to evaluate existing literature on 
the use of ECT to treat SIB, ASD 
youths. This review of material will 
be used in an attempt to assess and 
draw conclusions on the efficacy and 
ethical considerations of this practice 
while taking into account the unique 
population in question.  
Positive-only Treatment of 
Self-Injurious Behaviors
 First line interventions for 
SIB in ASD consists of a combin-
ation of behavioral and psycho-
pharmacological treatments (Weiss, 
2002). These first line interventions 
have proven to be effective when 
observable environmental circum-
stances appear to be maintaining 
the behaviors, or if an underlying 
psychotropic condition is present 
(Weiss, 2002). However, several 
clinical phenomena challenge the 
therapeutic primacy of first line 
interventions. Efficacy of these 
therapies differ from one clinical 
case to another due to the highly 
individualized nature of SIB in 
ASD (McCorkle, 2011). An ad-
ded complication is that only two 
antipsychotics, aripiprazole and 
risperidone, have been approved by 
the FDA for use in treating beha-
vioral impairments associated with 
autism and/or intellectual disabilities 
in children and adolescents (Consoli, 
et al., 2012). This is due, in part, to 
the significant side effects associated 
with antipsychotic use. Indeed, two 
meta-analyses of randomized, place-
bo-controlled trials of antipsychotics 
among children (Cohen, Bonnot, 
Bodeau, Consoli, & Laurent, 2012; 
De Hert, Dobbelaere, Sheridan, 
Cohen, & Correll, 2011), including 
aripiprazole and risperidone, have 
demonstrated that antipsychotic 
usage is linked to short term ex-
trapyramidal symptoms (move-
ment disorders such as restlessness, 
involuntary muscle contractions, 
pseudo-parkinsonism), cardio-meta-
bolic and endocrine side-effects, hy-
perprolactinaemia (elevated levels of 
the hormone prolactin), and weight 
gain (Cohen, Bonnot, Bodeau, Con-
soli, & Laurent, 2012). Lastly some 
patients display particularly severe 
forms of first line treatment-resistant 
SIB (Consoli, et al., 2012). It is this 
population that researchers look to 
in the debate on ECT.
The Efficacy of 
Electroconvulsive Therapy
 Despite the controversy that 
surrounds the use of ECT, a number 
of studies have demonstrated signi-
ficant treatment effects in cases of 
severe and treatment-resistant mood 
disorders (Ghaziuddin, Dumas & 
Hodges, 2011; Kessler, 2004; Ligas, 
Petrides, Istafanous & Kellner, 2009; 
Reinblatt, Rifkin & Freeman, 2004). 
The literature on clinical benefits 
of ECT use in cases of maladaptive 
behavioral conditions, especially in 
ASD, is considerably more sparse 
but warrants assessment. What 
follows is a summary of four studies 
– all of which involve small sample 
sizes – that demonstrate significant 
treatment benefits of ECT in cases 
of severe SIB. 
 The case of a sixteen year 
old male diagnosed with autism,  
catatonic symptoms, and severe SIB 
demonstrates the dramatic treatment 
effects of ECT (Haq & Ghaziuddin, 
2014). The patient had been hos-
pitalized due to an acute increase in 
SIB, such as biting himself, throwing 
himself against walls, and banging 
his head. After over a month of ad-
mission and the failure of pharmaco-
logical and behavioral management 
therapies, the patient was referred 
to ECT treatment. This resulted in 
gradual but dramatic improvement 
with aggressive episodes declining 
enough by the 16th session to allow 
for hospital discharge, school attend-
ance, and out-patient treatment. The 
tapering of treatment occurred over 
the next four months and ended 
with termination upon which the 
patient experienced a gradual decline 
in functioning and an increase in 
SIB. This development necessitated 
the reinstatement of ECT, which 
resulted in an immediate decrease 
in problematic behaviors and an 
increase in functioning. The tapering 
of the second treatment course res-
ulted in the same pattern of regres-
sion, which could not be mediated 
by antiepileptics. Electroconvulsive 
therapy was restarted again, leading 
to an immediate cessation of SIB, 
and a more effective tapering sched-
ule was identified. This case high-
lights the efficacy of ECT in man-
aging SIB and identifies the need 
for additional research into effective 
maintenance schedules and tapering 
trajectories for this particular treat-
ment method.
 The clinical case of an 
eight year old boy with autism, 
who presented a five-year history 
of extreme self-injury supports the 
findings of the previous research 
(Wachtel, et al., 2009). The patient’s 
SIB included slapping and punching 
his head, as well as banging his head 
on his knees and shoulders, with the 
frequency averaging 109.3 attempts 
hourly. Despite undergoing extens-
ive applied behavioral assessments, 
medication, and behavioral trials 
for three years, the patient showed 
little to no decrease in SIB. He also 
displayed significant mood instabil-
ity, with negative affect correlated 
to increase in SIB. Fifteen ECT 
treatments were administered over a 
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period of five weeks, three times per 
week with tapering towards the end. 
Significant improvement was noted 
after the first session alone. Overall, 
the rate of self-injury was reduced to 
6.5 attempts hourly with restraints 
and 19.4 without restraints. The re-
straints required were canvas sleeves 
and not the bilateral arm restraints 
and cervical immobilizer that were 
worn before treatment.
 Similarly, the case of an 
eleven  year old boy diagnosed with 
autism and concomitant psychotrop-
ic-resistant bipolar affective disorder 
demonstrates the efficacy of ECT in 
reducing severe SIB (Wachtel, Jaffe, 
& Kellner, 2011). Self-Injurious 
Behaviors consisted of a several-year 
history of hand-to-head injury, 
resulting in bleeding, a broken arm, 
and repeated hand-biting. Several 
years of extensive psychopharma-
cological interventions had failed 
to produce any lasting results so an 
acute ECT treatment was initiated, 
consisting of eight sessions over a 
course of 2.5 weeks. After the end 
of the acute treatment, clinical and 
parent observations recorded near 
extinction of SIB. Maintenance ther-
apy of once weekly sessions led to an 
intense violent outburst on Day 6 
post-acute treatment. The frequency 
of maintenance therapy was then 
increased leading to previously noted 
behavioral and affective stabilization 
and a return to normal, educational, 
and social activities. 
 The efficacy of ECT was 
demonstrated in the final case, to 
treat the catatonic symptoms of a 
teenage girl diagnosed with autism, 
who developed severe SIB at an early 
age (Wachtel, Kahng, Dhossche, 
Cascella, & Reti, 2008). Hand-
to-head, knee-to-head, and hand-
to-body self-injury were the most 
prevalent behaviors observed, in-
tensifying in frequency to hundreds 
of times hourly. The failure of mul-
tiple psychopharmacological ther-
apies led to the use of ECT  with 25 
treatments administered three times 
per week, and tapering to mainten-
ance levels. Self-Injurious Behaviors 
was reported to have markedly de-
creased by the ninth treatment and 
neared extinction towards the end of 
the therapy. Clinicians experimented 
with the placement of the leads, and 
discovered that bilateral placement 
delivered the best results. This high-
lights the need for further research in 
the clinical benefits of bilateral lead 
placement in ECT.
 In addition to these studies, 
a number of other clinical cases have 
revealed the significant treatment ef-
fects of ECT in managing severe psy-
chological disorders with concomit-
ant SIB (Black, Wilcox, & Stewart, 
1985; Carr, Dorrington, Schrader, 
& Wale, 1983; Chung & Varghese, 
2008; Cizadlo & Wheaton, 1995; 
Fink, 1999; Thuppal & Fink, 1999). 
Of these, the most relevant to this 
review are studies examining SIB 
and concomitant intellectual disab-
ilities (ID). A wealth of knowledge 
exists to demonstrate the overlap 
and similarities between ID and 
ASD as risk factors for predicting 
SIB (Bartak, Rutter, & Michael, 
1976; McClintock, Hall, & Oliver, 
2003). A retrospective study of the 
efficacy of ECT in treating severe 
and treatment- resistant SIB among 
a small sample of adolescents with 
ID (n=4) showed promising results 
(Consoli, et al., 2012). The SIB 
reported was severe in scale and in-
cluded repeated attempts of suicide, 
repeated head banging, attempts to 
remove an eye with a fork, and daily 
ingestion of objects. When compar-
ing the efficacy of ECT, mean SIB 
scores post-ECT were shown to be 
half of pre-ECT values. Three of the 
four patients transitioned to fewer 
restrictive environments, indicating 
the success of ECT in treating SIB in 
conditions highly related to ASD.
 Despite the relative suc-
cess of ECT in treating SIB, little 
knowledge exists on the underlying 
reasons of its efficacy. Researchers 
have presented several neurobio-
logical hypotheses, one being that 
SIB in some cases can be explained 
by monoamine dysfunction, which 
could potentially be reversed by 
ECT (Sanacora, et al., 2003). This 
theory posits that the treatment has 
been shown to increase GABA-ergic 
transmission, which other research 
indicates may correct the lack of 
GABA-led inhibition displayed in 
SIB (Schroeder, et al., 2001). Fur-
thermore, decreased dopamine and 
serotonin activity in SIB (Schroeder, 
et al., 2001) could be ameliorated by 
ECT (Yoshida, et al., 1998). Lastly, 
researchers have suggested that ECT 
achieves the normalization of HPA 
axis activity in SIB (Fink, 1999). 
Thus, evidence exists to support the 
theoretical conceptualization of the 
treatment efficacy of ECT in severe 
SIB.
Risks and Ethical 
Implications of ECT 
Treatment
 Proponents of the use of 
ECT claim that misperceptions 
regarding the treatment have biased 
mainstream clinical thought, leading 
to the underutilization of a pur-
portedly effective therapy. The Amer-
ican Psychiatric Association (APA) 
and the American Academy of Child 
and Adolescent Psychiatry (AACAP) 
consider ECT to be a viable option 
for children with certain affective, 
psychotic, and catatonic disorders 
(Consoli, et al., 2012). In 2004, the 
AACAP issued practice parameters 
on ECT in adolescence (AACAP Of-
21
Social Sciences
ficial, 2004). Nonetheless, a review 
of the literature concerning potential 
side-effects of ECT has been incor-
porated in this paper. Here I wish to 
note the paucity of literature explor-
ing the side-effects of ECT when 
applied to youth with ASD and SIB. 
Many of the studies reviewed in this 
section consider the risks posed to 
all populations undergoing treat-
ment, even adults and those with 
other conditions. However, it may 
be possible to draw inferences for 
the specific population in question 
through this analysis.
 The potential risks that ECT 
poses to any population can be 
divided into three broad categories 
according to the review of literature 
presented by Lawrence Park before 
the FDA Neurological Devices Panel 
in a deliberation of the reclassific-
ation of ECT (Food and Drugs 
Administration, 2011). Of these, 
the third category, one dealing with 
device malfunction, has been omit-
ted from this review in the interest 
of brevity. According to Park, the 
medical and physical risks of ECT 
include adverse reactions to anes-
thesia, cardiovascular complications, 
dental and oral trauma, physical 
trauma, pulmonary complications, 
skin burns, and strokes. These are 
classified as uncommon side effects 
and the risks of occurrence can be 
minimized by pre-ECT medical 
tests, assessments, gaining a detailed 
medical, surgical, and family his-
tory, and post-ECT monitoring and 
clinical management. Alterations in 
blood pressure pain, and discomfort 
are the two most common physical 
side effects – both reported to be be-
nign and transient in nature – which 
clinicians have to account for (Food 
and Drugs Administration, 2011). 
With regard to certain side effects 
such as cardiovascular complications, 
other research suggests that children 
may be at lesser risk than adults, 
who may have pre-existing medical 
conditions or risk factors (Wachtel, 
Dhosscheb, & Kellner, 2011). Most 
importantly, no pediatric deaths 
have been reported due to ECT (Rey 
& Walter, 1997). This suggests that 
while concerns of mild medical and 
physical risks exist, that they can be 
effectively managed by clinicians.
 The second category of risks 
deals with cognitive and memory 
impairment. Park’s review of liter-
ature demonstrates that immediate 
cognitive dysfunction, in the form 
of disorientation, may occur. This 
effect is observed to be transient and 
is expected to cease within minutes 
after treatment. Memory dysfunc-
tion is a more significant risk and 
deserves greater exploration. The 
research of Krulewitch and Como 
(2011) that was presented before 
the same FDA panel suggests that 
anterograde verbal memory deficits 
may result through ECT, which 
generally resolves within a few weeks 
post-treatment. Of greater con-
cern, according to Krulewitch and 
Como, is the risk of autobiograph-
ical memory deficits, with evidence 
suggesting that autobiographical 
memory performance is approxim-
ately 76-77% of baseline perform-
ance for right unilateral treatment 
and 58-67% for bilateral treatment. 
This is particularly significant as 
Wachtel and colleagues suggested 
the potential efficacy of bilateral lead 
placement in ECT (Wachtel, Kahng, 
Dhossche, Cascella, & Reti, 2008). 
Conflicting with this finding, two 
separate studies (Wachtel, Hermida, 
A, & Dhossche, 2010; Wachtel, 
Reti, Dhossche, Slomine, & Sanz, 
2011) maintain that bilateral place-
ment, even when continued over 
several years, did not lead to cog-
nitive impairments. This highlights 
the need for additional research to 
resolve this point of contention. 
Several factors may mitigate this par-
ticular risk, such as the use of certain 
types of currents (Food and Drugs 
Administration, 2011). 
 Research into risk of ret-
rograde amnesia post-ECT have 
concluded that while a loss of 
memory is observed immediately 
after treatment, by 3 months, retro-
grade memory had reached baseline 
levels and that anterograde memory 
appeared to be unaffected (Meeter, 
Murreb, Janssen, Birkenhager, & van 
den Broek, 2011). A study assessing 
learning and memory impairment 
among adult patients undergoing 
ECT for Bipolar Disorder shows 
that, even after adjusting for the 
inherent memory and learning 
dysfunction associated with the 
disorder, patients reported lower 
performance (MacQueen, Parkin, & 
Marriott, 2007). While the research-
ers have stated that this finding is 
unlikely to alter the risk-benefit 
ratio of the treatment significantly, 
it does highlight the importance of 
attending to the cognitive factors of 
patients before and following treat-
ment. One significant finding from 
this research is that patients receiving 
ECT are more likely to self-report 
memory impairment, which speaks 
for expectations which could af-
fect their performance in tests in a 
self-fulfilling prophecy effect. If this 
hypothesis is likely to be true, man-
aging patient expectations regarding 
ECT treatment could mitigate risks 
of memory impairment significantly. 
A study assessing cognitive function-
ing of adolescents with severe treat-
ment-resistant depression arrived 
at a contradictory result, indicating 
evidence of improved short-term 
memory and verbal learning as well 
as a statistically significant improve-
ment in long-term delayed memory 
recall (Ghaziuddin, Dumas, & 
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Hodges, 2011). These findings could 
perhaps be attributed to symptom 
relief, positive effect, greater motiv-
ation and increased psychomotor 
control that results through high 
treatment efficacy. Despite con-
tradictory findings, proponents of 
ECT argue that enough research has 
been conducted to dismiss the more 
serious claims of long term cognitive 
and memory impairment among 
youth (Cohen, et al., 2000; Ghazi-
uddin, et al., 1996; Walter, Koster, 
& Rey, 1999).
 With regard to the ethical 
implications of ECT use, guidelines 
such as those put forth by the 
AACAP confirm the importance of 
gaining the consent of parents/legal 
guardians and the patients. Em-
phasis is placed on educating both 
the patient and the parents/guardi-
ans on the benefits and risks of the 
treatment and granting both parties 
the right to reject treatment at any 
time once therapy has commenced. 
The consulting of an independent 
psychiatrist is another safeguard 
that has been instated, along with 
a seventy-two hour waiting period 
before treatment begins, allowing the 
patient and parents/guardians time 
to reflect on their choice. A poten-
tial ethical dilemma – one faced by 
all child mental health practition-
ers – arises if the patient and the 
parents disagree. If the use of ECT 
was to become more accepted, a 
question that requires consensus is 
at what point SIB is declared to be 
treatment-resistant and is referred to 
ECT. As the focus on early interven-
tions in SIB in ASD grows, it must 
be decided if there is any age that is 
considered too young for receiving 
ECT. Lastly, although clinicians are 
quick to declare pain experiences 
to be mild to moderate (Food and 
Drugs Administration, 2011) any 
potential significant pain occurring 
through ECT warrants attention 
given the ethical implications of 
subjecting children to treatment that 
is potentially painful. A growing 
body of research is challenging the 
misconception that ASD is asso-
ciated with higher pain thresholds 
or pain insensitivity (Allely, 2013). 
This research suggests that children 
with ASD may express pain in ways 
different to neurotypical children, 
which may lead to an underestim-
ation of pain experience. This is 
particularly relevant to the sub-pop-
ulation of patients with severe 
intellectual disabilities. Thus, further 
research is required to accurately 
gauge pain experience. 
While it is important to bear in 
mind the potential physical and cog-
nitive impairments that may occur as 
a result of ECT usage, active man-
agement of such situations, and ad-
herence to clinically tested guidelines 
may offer clinician the opportunity 
to minimize potential hazards.
Discussion
 A summary of the literature 
that exists on the subject of man-
aging and treating SIB of children 
and adolescents with ASD, demon-
strates that there is some evidence for 
the efficacy of ECT as a last-resort 
intervention for particularly severe 
and treatment-resistant cases. How-
ever, there are limitations to this re-
view that must be taken into account 
when interpreting the results. First, 
there is the possibility of certain 
relevant research being overlooked in 
the review process. It is of particular 
significance that no research was 
found to reveal the ineffectiveness or 
substantial risks of ECT in treating 
SIB in ASD. This may be explained 
by the limitation elucidated earlier, 
but it is notable that there is no 
easily available wealth of knowledge 
supporting this position. Given 
the dearth of research examining 
the unique side-effects that youth 
with ASD and SIB experience when 
undergoing ECT, another limita-
tion imposed upon this review was 
having to generalize side-effects of 
ECT use in other conditions to this 
particular context. Additionally, 
the studies that were reviewed were 
conducted over the past five decades, 
and thus there may exist varying 
standards in the quality of research 
and analysis, with a general trend of 
improvement over time. While every 
effort was made to use more recent 
materials, this limitation cannot 
be discounted. Related to this is 
an additional concern of varying 
diagnostic definitions and criteria as 
well as assessment tools being used 
across studies, potentially contrib-
uting to low reliability, validity and 
comparability. Lastly, all of the re-
search on efficacy and complications 
of ECT are single subject designs 
with no controlled trials, which may 
affect the generalizability of findings.
 It is, therefore, imperative 
that more research involving larger 
samples is conducted on the efficacy 
of ECT (e.g. unilateral vs. bilateral 
placement, tapering trajectories) and 
potential side effects (e.g. pain exper-
ience, mitigating effects on autobio-
graphical memory among others). It 
is of utmost importance that future 
research study populations of youth 
with ASD and symptoms of SIB spe-
cifically. While further research along 
streamlined, uniform, and universal 
standards is required to conclude 
authoritatively on the question of 
ECT use, the research exhibiting 
the treatment gains and risk-man-
agement capabilities of ECT cannot 
be denied. Therefore, this treatment 
carries significant potential to offer 
relief to those who do not respond to 
first-line interventions and have little 
hope.
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